ArticleFrontiers in endocrinology2022

Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes.

Miao-Ling Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.